BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences.
- Craig-Hallum 22nd Annual Institutional Investor Conference in Minneapolis, MN on Wednesday, May 28.
- Jefferies Global Healthcare Conference 2025 in New York, NY. Presentation on Thursday, June 5 at 10:30 a.m. ET.
- Goldman Sachs 46th Annual Global Healthcare Conference in Miami, FL. Fireside chat on Monday, June 9 at 3:20 p.m. ET.
To listen to the webcast for the June 5th and June 9th events, please visit the Events & Presentations section of CareDx’s Investor Relations website at: www.investors.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
Contacts
Investor Relations
Caroline Corner
investor@caredx.com
